Rtw Investments, Lp - Sep 23, 2022 Form 4 Insider Report for Landos Biopharma, Inc. (LABP)

Role
10%+ Owner
Signature
RTW Investments, LP, By: /s/ Roderick Wong, Managing Partner
Stock symbol
LABP
Transactions as of
Sep 23, 2022
Transactions value $
-$207,000
Form type
4
Date filed
9/27/2022, 04:30 PM
Previous filing
Sep 9, 2022
Next filing
Oct 11, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction LABP Common Stock Sale -$207K -300K -7.02% $0.69 3.98M Sep 23, 2022 See footnote F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Rtw Investments, Lp is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may continue.

Explanation of Responses:

Id Content
F1 This Form 4 is being filed by each of (i) RTW Investments, LP (the "Adviser") with respect to the shares of common stock held by certain investment funds managed by the Adviser (the "RTW Funds") and (ii) Roderick Wong, M.D., who serves as the Managing Partner and Chief Investment Officer of the Adviser.

Remarks:

Each Reporting Person disclaims beneficial ownership in the securities reported on this Form 4 except to the extent of its or his pecuniary interest, if any, therein, and this report shall not be deemed to be an admission that such Reporting Person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose.